Filing metadata

Accession number
0000950170-24-138132
Form type
Form 4
Filer
Akero Therapeutics, Inc.
CIK
CIK 1744659
Filed
Dec 18, 2024
Reporting period
Dec 16, 2024
Description
Insider transaction

Explore SEC Filings Hub